3646 Angiotensin-converting enzyme inhibitor therapy reduces the vascular oxidative state in patients with newly diagnosed type II diabetes mellitus

Type Ii Diabetes ◽

Enzyme Inhibitor ◽

Type Ii ◽

Converting Enzyme ◽

Newly Diagnosed ◽

Oxidative State

Angiotensin converting enzyme inhibitor therapy reduces the vascular oxidative state in normotensive patients with newly diagnosed type 2 diabetes mellitus

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(03)82335-5 ◽

2003 ◽

Vol 41 (6) ◽

pp. 285

Author(s):

Bobby V. Khan ◽

Rekha G. Menon ◽

Stamtios Lerakis

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Newly Diagnosed ◽

Oxidative State

Scintigraphic Evaluation of Functional Renal Reserve Using Angiotensin-Converting Enzyme Inhibition in Patients with Type II Diabetes Mellitus

American Journal of Nephrology ◽

10.1159/000168619 ◽

1993 ◽

Vol 13 (3) ◽

pp. 203-209

Author(s):

Belkis Erbas ◽

Tomris Erbas ◽

Sema Akalin ◽

Erhan Varoglu ◽

Zehra Koray ◽

...

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibition ◽

Type Ii Diabetes ◽

Angiotensin Converting Enzyme Inhibition ◽

Type Ii ◽

Converting Enzyme ◽

Converting Enzyme Inhibition

SPIRONOLACTONE FURTHER REDUCES URINARY ALBUMIN EXCRETION AND PLASMA B-TYPE NATRIURETIC PEPTIDE LEVLES IN HYPERTENSIVE TYPE II DIABETES TREATED WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITOR

Clinical and Experimental Pharmacology and Physiology ◽

10.1111/j.1440-1681.2006.04390.x ◽

2006 ◽

Vol 33 (5-6) ◽

pp. 477-479 ◽

Cited By ~ 19

Author(s):

Susumu Ogawa ◽

Kazuhisa Takeuchi ◽

Takefumi Mori ◽

Kazuhiro Nako ◽

Sadayoshi Ito

Keyword(s):

Natriuretic Peptide ◽

Type Ii Diabetes ◽

Urinary Albumin Excretion ◽

Enzyme Inhibitor ◽

Urinary Albumin ◽

Type Ii ◽

Converting Enzyme ◽

Differential metabolic responses to physiological meal and glucose tolerance tests in newly-diagnosed type ii diabetes mellitus

Journal of Steroid Biochemistry ◽

10.1016/0022-4731(84)90659-9 ◽

1984 ◽

Vol 20 (6) ◽

pp. 1487

Author(s):

I.R. Jones ◽

D.R. Owens ◽

S. Luzio ◽

C.J. Davies

Keyword(s):

Diabetes Mellitus ◽

Glucose Tolerance ◽

Type Ii Diabetes ◽

Metabolic Responses ◽

Type Ii ◽

Newly Diagnosed ◽

Glucose Tolerance Tests

Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin

Hypertension ◽

10.1161/hypertensionaha.116.07797 ◽

2016 ◽

Vol 68 (3) ◽

pp. 606-613 ◽

Cited By ~ 17

Author(s):

William B. White ◽

Craig A. Wilson ◽

George L. Bakris ◽

Richard M. Bergenstal ◽

Christopher P. Cannon ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 27)

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2012.02.001 ◽

2012 ◽

Vol 26 (2) ◽

pp. 123-128 ◽

Cited By ~ 39

Author(s):

Rajiv Raman ◽

Aditi Gupta ◽

Suganeswari Krishna ◽

Vaitheeswaran Kulothungan ◽

Tarun Sharma

Keyword(s):

Diabetes Mellitus ◽

Risk Factors ◽

Type Ii Diabetes ◽

Microvascular Complications ◽

Molecular Genetic ◽

Diabetic Microvascular Complications

Type Ii ◽

Newly Diagnosed ◽

Molecular Genetic Study ◽

Impaired Vascular Reactivity in African-American Patients with Type 2 Diabetes Mellitus and Microalbuminuria or Proteinuria Despite Angiotensin-Converting Enzyme Inhibitor Therapy

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2005-1632 ◽

2006 ◽

Vol 91 (1) ◽

pp. 31-35 ◽

Cited By ~ 30

Author(s):

A. Jawa ◽

S. Nachimuthu ◽

M. Pendergrass ◽

S. Asnani ◽

V. Fonseca

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

African American ◽

Vascular Reactivity ◽

Enzyme Inhibitor ◽

Converting Enzyme

Hypoglycemia Associated with the Administration of Angiotensin-Converting Enzyme Inhibitor in a Patient with Diabetes Mellitus.

Internal Medicine ◽

10.2169/internalmedicine.36.77 ◽

1997 ◽

Vol 36 (1) ◽

pp. 77

Author(s):

Hiromi SAKAGUCHI ◽

Shinya MAEDA ◽

Yasutomo FUKUNAGA ◽

Daisuke INOUE ◽

Hiroyuki KOSHIYAMA

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Beta-Blocker Treatment Before Angiotensin-Converting Enzyme Inhibitor Therapy in Newly Diagnosed Heart Failure

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2005.04.011 ◽

2005 ◽

Vol 46 (1) ◽

pp. 182 ◽

Cited By ~ 1

Author(s):

Ronnie Willenheimer ◽

Dirk J. van Veldhuisen ◽

Piotr Ponikowski ◽

Philippe Lechat

Keyword(s):

Heart Failure ◽

Beta Blocker ◽

Enzyme Inhibitor ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Newly Diagnosed ◽

Reduction of microalbuminuria in type-2 diabetes mellitus with angiotensin-converting enzyme inhibitor alone and with cilnidipine

Indian Journal of Nephrology ◽

10.4103/0971-4065.151764 ◽

2015 ◽

Vol 25 (6) ◽

pp. 334 ◽

Cited By ~ 6

Author(s):

VK Singh ◽

A Mishra ◽

KK Gupta ◽

R Misra ◽

ML Patel ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽